1. $IPCI Sorry I didn t know you were only retail trader

  2. $IPCI Stock research45 shouldn t be in stocks if he doesn t know retail can t short stks under $5. Options don t trade enough to buy puts

  3. $IPCI @Vanderbilt Put your money where your mouth is and short $IPCI!!

  4. #biotech #buy #stocks $CYTR $ADXS $CPRX $CLDX $SPPI $IPCI $OCRX $CYCC $IMMU $ALXA $NVAX $ABIO and others http://www.michele-ciani.com/StockTrader/Stocks.html

  5. $IPCI over SMA50 could move to $3.5 in few days. LONG

  6. $IPCI Maxim Maintains Buy On Intellipharmaceutics Following Regabatatin XR Update http://www.smarteranalyst.com/2014/10/23/maxim-maintains-buy-intellipharmaceutics-following-regabatatin-xr-update/

  7. @Vanderbilt $IPCI you must of bought in over $6 PS b/c its always a bash fest with you on this co. Its a small 65M co what do you expect!

  8. $IPCI Notice that this is supposed to be new drug but it is based on substance under patent. This co has nothing original and no innovation

  9. @IPCI: We Are Reporting Positive Results from a Series of Phase I Clinical Trials of Regabatin(TM) XR $IPCI http://pcgadvisory.com/news/intellipharmaceutics-reports-positive-results-from-a-series-of-phase-i-clinical-trials-of-regabatintm-xr-pregabalin-extended-release/

  10. $IPCI Wow. Such impressive news. Worth a 4 cent move in the stock. This company is a joke.

  11. We Are Reporting Positive Results from a Series of Phase I Clinical Trials of Regabatin(TM) XR $IPCI http://pcgadvisory.com/news/intellipharmaceutics-reports-positive-results-from-a-series-of-phase-i-clinical-trials-of-regabatintm-xr-pregabalin-extended-release/

  12. $IPCI Intellipharmaceutics reports positive results from Regabatin phase 1 trials

  13. #biotech #buy #stocks $RNN $RPRX $OCRX $CYCC $KBIO $ECYT $IPCI $SPHS $LPDX $VSTM $AEZS $AGEN and others http://www.michele-ciani.com/StockTrader/Stocks.html

  14. $IPCI trials involving a twice-a-day formulation and a once-a-day formulation.

  15. $IPCI the company s non-generic pregabalin formulations. The company has recently conducted and analyzed the results of six phase I clinical

  16. $IPCI provided an update on the progress of its Regabatin XR product development. Regabatin XR pregabalin extended release capsules are

  17. Report of foreign issuer [Rules 13a-16 and 15d-16] http://www.conferencecalltranscripts.org/summary/?id=1213494 $IPCI

  18. Is $IPCI a BUY? Brean Murray, Carret & Co. thinks so:http://investorwand.com/investor/5939/jonathan-aschoff

  19. $IPCI financial datas release were good, good potential monitoring for re entry here

  20. $IPCI bouncing from $2.5 support

  21. We Have Announced Third Quarter 2014 Results $IPCI http://pcgadvisory.com/news/intellipharmaceutics-announces-third-quarter-2014-results/

  22. Intellipharmaceutics Announces Third Quarter 2014 Results $IPCI http://pcgadvisory.com/news/intellipharmaceutics-announces-third-quarter-2014-results/

  23. $IPCI Brean Capital Reiterates Buy On Intellipharmaceutics Following FY3Q14 Results http://www.smarteranalyst.com/2014/10/16/brean-capital-reiterates-buy-intellipharmaceutics-following-fy3q14-results/

  24. IntelliPharmaCeutics Intl announces earnings. ($0.07) EPS. Misses estimates. $IPCI http://www.analystratings.net/stocks/NASDAQ/IPCI/?RegistrationCode=SocialMedia-direct&DefaultTab=Earnings

  25. Intellipharmaceutics International Inc. just filed its Report of foreign issuer [Rules 13a-16 and 15d-16] http://www.conferencecalltranscripts.org/include/?location=http://www.sec.gov/Archives/edgar/data/1474835/000117184314004784/0001171843-14-004784-index.htm $IPCI